Antifibrotic constituents from Garcinia mangostana

Natural Product Communications

Volumn 6, Issue 9, 2011, Pages 1267-1268

  Chin, Young Won ^a   Shin, Eunjin ^b   Hwang, Bang Yeon ^b   Lee, Mi Kyeong ^b  

^a Dongguk University   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Clusiaceae; Garcinia mangostana; HSC T6 cells; Liver fibrosis; Mangostin; Xanthone

Indexed keywords

1 ISOMANGSTANIN; ALPHA MANGOSTIN; ANTIFIBROTIC AGENT; CHLOROFORM; COLLAGEN; DEOXYGARTANIN; GAMMA MANGOSTIN; GARCINIA MANGOSTANA EXTRACT; GARCINONE; GARTANIN; LACTATE DEHYDROGENASE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ARTICLE; CELL ASSAY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; FRUIT; GARCINIA MANGOSTANA; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL MEMBRANE; MEMBRANE DAMAGE; PROTEIN CONTENT; SOLVENT EXTRACTION; STELLATE CELL; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GARCINIA; RAT;

CLUSIACEAE; GARCINIA MANGOSTANA;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; GARCINIA; HEPATIC STELLATE CELLS; MOLECULAR STRUCTURE; RATS; XANTHONES;

EID: 80155126637     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1100600915     Document Type: Article

References (12)

1. (a) Li D, Friedman SL. (1999) Liver figrogenesis and the role of hepatic stellate cells: new insight and prospects for therapy. Journal of Gastroenterology and Hepatology, 14, 618-633;
2. (b) Tsukada S, Parsons CJ, Rippe RA. (2006) Mechanism of liver fibrosis. Clinical Chimica Acta, 364, 33-60;
3. (c) Batallar R, Brenner DA. (2005) Liver fibrosis. Journal of Clinical Investigation, 115, 209-218.
4. Wu J, Zern MA. (2000) Hepatic stellate cells: A target for the treatment of liver fibrosis. Journal of Gastroenterology, 35, 665-672.
5. Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. (2009) Garcinia mangostana L.: a phytochemical and pharmacological review. Phytotherapy Research, 23, 1047-1065.
6. (a) Han AR, Kim JA, Lantvit DD, Kinghorn AD. (2009) Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). Journal of Natural Products, 72, 2028-2031;
7. (b) Chen LG, Yang LL, Wang CC. (2008) Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chemistry and Toxicology, 46, 688-693.
8. (a) Suksamrarn S, Komutiban O, Ratananukul P, Chimnoi N, Lartpornmatulee N, Suksamrarn A. (2006) Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chemical and Pharmaceutial Bulletin, 54, 301-305;
9. (b) Mahabusarakim W, Wiriyachitra P, Taylor WC. (1987) Chemical constituents of Garcinia mangostana. Journal of Natural Products, 50, 474-478. (Pubitemid 17134099)
10. (a) Lee MK, Yang H, Yoon JS, Jeong EJ, Kim DY, Ha NR, Sung SH, Kim YC. (2008) Antifibrotic activity of diterpenes from Biota orientalis leaves on hepatic stellate cells. Archives of Pharmacal Research, 31, 866-871;
11. (b) Quan GH, OH SR, Kim JH, Lee HK, Kinghorn AD, Chin YW. (2010) Xanthone constituents of the fruits of Garcinia mangostana with anticomplement activity. Phytotherapy Research, 24, 1575-1577;
12. (c) Jung HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD. (2006) Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). Journal of Agricultural Food and Chemistry, 54, 2077-2082.